Search Results

Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Added to Dual or Triple Treatment in Patients with Type 2 Diabetes Mellitus.

• Authors : Hong, Yesol¹ (AUTHOR); Jeon, Yoomin^2,3 (AUTHOR); Choi, Yoona^2,3 (AUTHOR)

Subjects: *SODIUM-glucose cotransporter 2 inhibitors; *TYPE 2 diabetes; *GLYCOSYLATED hemoglobinSOUTH KoreaSOUL Taehakkyo

• Source: Diabetes Therapy. Feb2024, Vol. 15 Issue 2, p487-496. 10p.

Record details

Geschlechtsspezifische Unterschiede in der Progression von diabetischen Nierenerkrankungen.

• Authors : Gerdes, Christian; Wolf, Gunter; Loeffler, Ivonne

• Source: Die Nephrologie; Jan2024, Vol. 19 Issue 1, p3-12, 10p

Record details

Neue Aspekte der medikamentösen Nephroprotektion.

• Authors : Beimler, Jörg

• Source: Der Internist; Nov2022, Vol. 63 Issue 11, p1200-1207, 8p

Record details

Herzinsuffizienz bei Menschen mit Diabetes mellitus.

• Authors : Schütt, Katharina A.

• Source: Der Diabetologe; Jul2021, Vol. 17 Issue 5, p607-617, 11p

Record details

Gliflozine – in Zukunft Kardioprotektiva?

• Authors : Rauch-Kröhnert, Ursula; Landmesser, Ulf

• Source: Der Internist; Jul2021, Vol. 62 Issue 7, p786-795, 10p

Record details

Metabolische Azidose mit überraschender Ursache bei einer 61-jährigen Patientin.

• Authors : Koyro, T. F.; Thottakara, T.; Huber, T. B.

• Source: Der Internist; May2021, Vol. 62 Issue 5, p549-554, 6p

Record details

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol.

• Authors : Hinton, William; Feher, Michael D.; Munro, Neil

Subjects: TYPE 2 diabetes; GENERAL practitioners; DEMOGRAPHIC characteristicsUNITED KingdomROYAL College of General Practitioners; ASTRAZENECA PLC

• Source: Diabetes Therapy; Jun2019, Vol. 10 Issue 3, p1163-1170, 8p

Record details

Kardiovaskuläre Aspekte der Diabetestherapie.

• Authors : Forst, T.; Plum-Mörschel, L.; Weber, M.

• Source: Der Internist; Mar2017, Vol. 58 Issue 3, p293-302, 10p

Record details

Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study.

• Authors : Kim, Hae Jin¹ (AUTHOR); Kim, Young Sik² (AUTHOR); Lee, Chang Beom³ (AUTHOR)

Subjects: *CD26 antigen; *TYPE 2 diabetes; *SODIUM-glucose cotransporters

• Source: Diabetes Therapy. Nov2021, Vol. 12 Issue 11, p2907-2920. 14p.

Record details

Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

• Authors : Wang, Xin¹; Zhang, Fengyi¹; Zhang, Yufeng¹

Subjects: *BONE metabolism; *BIOMARKERS; *ONLINE information services

• Source: Osteoporosis International. Dec2023, Vol. 34 Issue 12, p2013-2025. 13p.

Record details